Cite
Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
MLA
Tian Y, et al. “Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer.” International Journal of General Medicine, vol. ume 15, Jan. 2022, pp. 803–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.9aafed50f045488ea6289cddf4a466bc&authtype=sso&custid=ns315887.
APA
Tian Y, Zhou Y, Liu J, Yi L, Gao Z, Yuan K, & Tong J. (2022). Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer. International Journal of General Medicine, ume 15, 803–816.
Chicago
Tian Y, Zhou Y, Liu J, Yi L, Gao Z, Yuan K, and Tong J. 2022. “Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer.” International Journal of General Medicine ume 15 (January): 803–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.9aafed50f045488ea6289cddf4a466bc&authtype=sso&custid=ns315887.